Association of Helicobacter pylori with coronary artery disease and myocardial infarction assessed by myocardial perfusion imaging

Israel Medical Association Journal

Volumn 16, Issue 6, 2014, Pages 341-346

  Shmuely, Haim ^a,b   Wattad, Morad ^c   Solodky, Alejandro ^d,e   Yahav, Jacob ^a,b   Samra, Zmira ^d,e   Zafrir, Nili ^d,e  

^a KAPLAN MEDICAL CENTER   (Israel)

^b HADASSAH HEBREW UNIVERSITY MEDICAL CENTER   (Israel)

^c CLALIT HEALTH SERVICES   (Israel)

^d RABIN MEDICAL CENTER   (Israel)

^e TEL AVIV UNIVERSITY   (Israel)

Author keywords

CagA; Coronary artery disease (CAD); Helicobacter pylori; Myocardial infarction (MI); Myocardial perfusion scan

Indexed keywords

AGED; ANTIGENS, BACTERIAL; BACTERIAL PROTEINS; CORONARY ARTERY BYPASS; CORONARY ARTERY DISEASE; ELECTROCARDIOGRAPHY; EXERCISE TEST; FEMALE; HELICOBACTER INFECTIONS; HELICOBACTER PYLORI; HUMANS; IMMUNOGLOBULIN G; MALE; MIDDLE AGED; MYOCARDIAL INFARCTION; MYOCARDIAL PERFUSION IMAGING; PERCUTANEOUS CORONARY INTERVENTION; PROSPECTIVE STUDIES; RISK FACTORS; SOCIOECONOMIC FACTORS; TERTIARY CARE CENTERS;

EID: 84904334901     PISSN: 15651088     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (20)

1. Hansson GK. Inflammation, atherosclerosis, and coronary artery disease. N Engl J Med 2005; 352: 1685-95.
2. Prasad A, Zhu J, Halcox JP, Waclawiw MA, Epstein SE, Quyyumi AA. Pre- disposition to atherosclerosis by infections: role of endothelial dysfunction. Circulation 2002; 106: 184-90.
3. Atherton JC, Blaser MJ. Coadaptation of Helicobacter pylori and humans: ancient history, modern implications. J Clin Invest 2009; 119: 2475-87.
4. Ozdogru I, Kalay N, Dogan A, et al. The relationship between Helicobacter pylori IgG titre and coronary atherosclerosis. Acta Cardiol 2007; 62: 501-5.
5. Kahan T, Lundman P, Olsson G, Wendt M. Greater than normal prevalence of seropositivity for Helicobacter pylori among patients who have suffered myocardial infarction. Coron Artery Dis 2000; 11: 523-6.
6. Kowalski M. Helicobacter pylori (H. pylori) infection in coronary artery disease: influence of H. pylori eradication on coronary artery lumen after percutaneous transluminal coronary angioplasty. The detection of H. pylori specific DNA in human coronary atherosclerotic plaque. J Physiol Pharmacol 2001; 52: 3-31.
7. Zhu J, Quyyumi AA, Muhlestein JB, et al. Lack of association of Helicobacter pylori infection with coronary artery disease and frequency of acute myocardial infarction or death. Am J Cardiol 2002; 89: 155-8.
8. Kanbay M, Gür G, Yücel M, Yilmaz U, Muderrisoglu H. Helicobacter pylori seroprevalence in patients with coronary artery disease. Dig Dis Sci 2005; 50: 2071-4.
9. Franceschi F, Niccoli G, Ferrante G, et al. CagA antigen of Helicobacter pylori and coronary instability: insight from a clinico-pathological study and a meta-analysis of 4241 cases. Atherosclerosis 2009; 202: 535-42.
10. Koenig W, Rothenbacher D, Hoffmeister A, et al. Infection with Helicobacter pylori is not a major independent risk factor for stable coronary heart disease: lack of a role of cytotoxin-associated protein A-positive strains and absence of a systemic inflammatory response. Circulation 1999; 100: 2326-31.
11. Gibbons RS. American Society of Nuclear Cardiology project on myocardial perfusion imaging: measuring outcomes in response to emerging guidelines. J Nucl Cardiol 1996; 3: 436-42.
12. Mowatt G, Vale L, Brazzelli M, et al. Systematic review of the effectiveness and cost-effectiveness, and economic evaluation, of myocardial perfusion scintigraphy for the diagnosis and management of angina and myocardial infarction. Health Technol Assess 2004; 8: 1-207.
13. Nishimura T, Nakajima K, Kusuoka H, Yamashina A, Nishimura S. Prognostic study of risk stratification among Japanese patients with ischemic heart disease using gated myocardial perfusion SPECT: JACCESS study. Eur J Nucl Med Mol Imaging 2008; 35: 319-28.
14. Zafrir N, Mats I, Solodky A, Ben-Gal T, Battler A. Characteristics and outcome of octogenarian population referred for myocardial perfusion imaging. Comparison with non octogenarian population with reference to gender. Clin Cardiol 2006; 29; 117-20.
15. Sanchez A, Mirabel JL, Barrenechea E, Eugui J, Puelles A, Castaneda A. Evaluation of an improved immunoturbidimetic assay for serum C-reactive protein on a COBAS INTEGRA 400 analyzer. Clin Lab 2002; 48: 313-17.
16. Jafarzadeh A, Esmaeeli-Nadimi A, Nemati M, Tahmasbi M, Ahmadi P. Serum concentrations of Helicobacter pylori IgG and the virulence factor CagA in patients with ischaemic heart disease. East Mediterr Health J 2010; 16: 1039-44.
17. Pellicano R, Parravicini PP, Bigi R, et al. Infection by Helicobacter pylori and acute myocardial infarction. Do cytotoxic strains make a difference? New Microbiol 2002; 25: 315-21.
18. Rayer P. Memoire sur 1'ossification morbide, considered commeune terminaison des phlegmasies. Arch Gen Med J (Paris) 1923; 1: 313-19.
19. Gaudio E, Carpino G, Grassi M, Musca A. Morphological aspects of atherosclerosis lesion: past and present. Clin Ter 2006; 157: 135-42.
20. Kher N, Marsh JD. Pathobiology of atherosclerosis - a brief review. Semin Thromb Hemost 2004; 30: 665-72.